186 related articles for article (PubMed ID: 22948216)
1. Phosphodiesterase type 5 inhibition reverts prostate fibroblast-to-myofibroblast trans-differentiation.
Zenzmaier C; Kern J; Sampson N; Heitz M; Plas E; Untergasser G; Berger P
Endocrinology; 2012 Nov; 153(11):5546-55. PubMed ID: 22948216
[TBL] [Abstract][Full Text] [Related]
2. Characterization of phosphodiesterase type 5 expression and functional activity in the human male lower urinary tract.
Fibbi B; Morelli A; Vignozzi L; Filippi S; Chavalmane A; De Vita G; Marini M; Gacci M; Vannelli GB; Sandner P; Maggi M
J Sex Med; 2010 Jan; 7(1 Pt 1):59-69. PubMed ID: 19796053
[TBL] [Abstract][Full Text] [Related]
3. Attenuated proliferation and trans-differentiation of prostatic stromal cells indicate suitability of phosphodiesterase type 5 inhibitors for prevention and treatment of benign prostatic hyperplasia.
Zenzmaier C; Sampson N; Pernkopf D; Plas E; Untergasser G; Berger P
Endocrinology; 2010 Aug; 151(8):3975-84. PubMed ID: 20555034
[TBL] [Abstract][Full Text] [Related]
4. PDE5 inhibitors blunt inflammation in human BPH: a potential mechanism of action for PDE5 inhibitors in LUTS.
Vignozzi L; Gacci M; Cellai I; Morelli A; Maneschi E; Comeglio P; Santi R; Filippi S; Sebastianelli A; Nesi G; Serni S; Carini M; Maggi M
Prostate; 2013 Sep; 73(13):1391-402. PubMed ID: 23765639
[TBL] [Abstract][Full Text] [Related]
5. Activators and stimulators of soluble guanylate cyclase counteract myofibroblast differentiation of prostatic and dermal stromal cells.
Zenzmaier C; Kern J; Heitz M; Plas E; Zwerschke W; Mattesich M; Sandner P; Berger P
Exp Cell Res; 2015 Nov; 338(2):162-9. PubMed ID: 26410556
[TBL] [Abstract][Full Text] [Related]
6. Testosterone/estradiol ratio regulates NO-induced bladder relaxation and responsiveness to PDE5 inhibitors.
Vignozzi L; Filippi S; Morelli A; Comeglio P; Cellai I; Sarchielli E; Maneschi E; Mancina R; Gacci M; Vannelli GB; Maggi M
J Sex Med; 2012 Dec; 9(12):3028-40. PubMed ID: 23057807
[TBL] [Abstract][Full Text] [Related]
7. Vardenafil modulates bladder contractility through cGMP-mediated inhibition of RhoA/Rho kinase signaling pathway in spontaneously hypertensive rats.
Morelli A; Filippi S; Sandner P; Fibbi B; Chavalmane AK; Silvestrini E; Sarchielli E; Vignozzi L; Gacci M; Carini M; Vannelli GB; Maggi M
J Sex Med; 2009 Jun; 6(6):1594-1608. PubMed ID: 19473460
[TBL] [Abstract][Full Text] [Related]
8. The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil.
Saenz de Tejada I; Angulo J; Cuevas P; Fernández A; Moncada I; Allona A; Lledó E; Körschen HG; Niewöhner U; Haning H; Pages E; Bischoff E
Int J Impot Res; 2001 Oct; 13(5):282-90. PubMed ID: 11890515
[TBL] [Abstract][Full Text] [Related]
9. In vitro effects of PDE5 inhibitors sildenafil, vardenafil and tadalafil on isolated human ureteral smooth muscle: a basic research approach.
Gratzke C; Uckert S; Kedia G; Reich O; Schlenker B; Seitz M; Becker AJ; Stief CG
Urol Res; 2007 Feb; 35(1):49-54. PubMed ID: 17102958
[TBL] [Abstract][Full Text] [Related]
10. A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway.
Sahara M; Sata M; Morita T; Nakajima T; Hirata Y; Nagai R
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1315-24. PubMed ID: 20413734
[TBL] [Abstract][Full Text] [Related]
11. Powerful relaxation of phosphodiesterase type 4 inhibitor rolipram in the pig and human bladder neck.
Ribeiro ASF; Fernandes VS; Martínez-Sáenz A; Martínez P; Barahona MV; Orensanz LM; Blaha I; Serrano-Margüello D; Bustamante S; Carballido J; García-Sacristán A; Prieto D; Hernández M
J Sex Med; 2014 Apr; 11(4):930-941. PubMed ID: 24754330
[TBL] [Abstract][Full Text] [Related]
12. Characterization and functional role of androgen-dependent PDE5 activity in the bladder.
Filippi S; Morelli A; Sandner P; Fibbi B; Mancina R; Marini M; Gacci M; Vignozzi L; Vannelli GB; Carini M; Forti G; Maggi M
Endocrinology; 2007 Mar; 148(3):1019-29. PubMed ID: 17138653
[TBL] [Abstract][Full Text] [Related]
13. Stromal insulin-like growth factor binding protein 3 (IGFBP3) is elevated in the diseased human prostate and promotes ex vivo fibroblast-to-myofibroblast differentiation.
Sampson N; Zenzmaier C; Heitz M; Hermann M; Plas E; Schäfer G; Klocker H; Berger P
Endocrinology; 2013 Aug; 154(8):2586-99. PubMed ID: 23720424
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effects of BAY 60-4552 and vardenafil on relaxation of corpus cavernosum tissue of patients with erectile dysfunction and clinical phosphodiesterase type 5 inhibitor failure.
Albersen M; Linsen L; Tinel H; Sandner P; Van Renterghem K
J Sex Med; 2013 May; 10(5):1268-77. PubMed ID: 23421435
[TBL] [Abstract][Full Text] [Related]
15. Effects of phosphodiesterase inhibitors on tension induced by norepinephrine and accumulation of cyclic nucleotides in isolated human prostatic tissue.
Uckert S; Sormes M; Kedia G; Scheller F; Knapp WH; Jonas U; Stief CG
Urology; 2008 Mar; 71(3):526-30. PubMed ID: 18342202
[TBL] [Abstract][Full Text] [Related]
16. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
[TBL] [Abstract][Full Text] [Related]
17. Vardenafil and resveratrol synergistically enhance the nitric oxide/cyclic guanosine monophosphate pathway in corpus cavernosal smooth muscle cells and its therapeutic potential for erectile dysfunction in the streptozotocin-induced diabetic rat: preliminary findings.
Fukuhara S; Tsujimura A; Okuda H; Yamamoto K; Takao T; Miyagawa Y; Nonomura N; Okuyama A
J Sex Med; 2011 Apr; 8(4):1061-71. PubMed ID: 21269399
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cyclic GMP hydrolysis in human corpus cavernosum smooth muscle cells by vardenafil, a novel, selective phosphodiesterase type 5 inhibitor.
Kim NN; Huang YH; Goldstein I; Bischoff E; Traish AM
Life Sci; 2001 Sep; 69(19):2249-56. PubMed ID: 11669467
[TBL] [Abstract][Full Text] [Related]
19. Nebivolol potentiates the efficacy of PDE5 inhibitors to relax corpus cavernosum and penile arteries from diabetic patients by enhancing the NO/cGMP pathway.
Martínez-Salamanca JI; La Fuente JM; Cardoso J; Fernández A; Cuevas P; Wright HM; Angulo J
J Sex Med; 2014 May; 11(5):1182-92. PubMed ID: 24877179
[TBL] [Abstract][Full Text] [Related]
20. Acute vardenafil administration improves bladder oxygenation in spontaneously hypertensive rats.
Morelli A; Filippi S; Comeglio P; Sarchielli E; Chavalmane AK; Vignozzi L; Fibbi B; Silvestrini E; Sandner P; Gacci M; Carini M; Vannelli GB; Maggi M
J Sex Med; 2010 Jan; 7(1 Pt 1):107-20. PubMed ID: 19889145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
